Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Liver X receptors are negative regulators of cardiac hypertrophy via suppressing NF-kB signalling
Cardiovascular Research, 09/16/09
Wu S et al. – XRs are negative regulators of cardiac growth and inflammation via suppressing NF–kB signalling in cardiomyocytes. This should provide new insights into novel therapeutic targets for treating cardiac hypertrophy and heart failure.
Today in Heart Failure...keeping you current
Receive free subspecialty "5-minute updates" via email
Omega-3 fatty acids and heart failure
Current Atherosclerosis Reports, 11/12/09
Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial
The Lancet - Early Online Publication, 11/18/09
Coenzyme Q10; an adjunctive therapy for congestive heart failure?
New Zealand Medical Journal, 11/04/09
Today in Physiology...keeping you current
Receive free subspecialty "5-minute updates" via email
Obesity-Related Cardiorenal Syndrome
The Journal of Clinical Hypertension, 10/20/09
The Effects of Resistance Training on Metabolic Health With Weight Regain
The Journal of Clinical Hypertension, 11/04/09
Usefulness of Various Plasma Biomarkers for Diagnosis of Heart Failure in Children With Single Ventricle Physiology
The American Journal of Cardiology, 10/27/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


